Dr. James Thomas Sing Jr., DO

Dr. Sing practices at Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas.

Dr. Sing's NPI, 1669434072, was assigned on April 3, 2006. Dr. Sing graduated from Texas College of Osteopathic Medicine in 1997. Dr. Sing holds Texas license K5694.

Dr. Sing's primary practice is Baylor Scott & White Continuing Care Hospital - Temple, at 2401 South 31st St, Temple, TX 76504 in Bell County. The practice phone is (254) 771-8200.

Dr. Sing's primary practice is Baylor Scott & White Continuing Care Hospital - Temple in Temple, Texas. Dr. Sing is also affiliated with Baylor Scott & White Medical Center - Temple. The medical group on file is Baylor Scott & White Temple Roney Bone and Joint Institute, Temple. Dmand AI also links Dr. Sing to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sing practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sing's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sing is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Sing is licensed in Texas.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids and intestinal or bowel obstruction among the conditions Dr. Sing treats.

CMS data shows 492 Medicare services from Dr. Sing across 14 procedure codes in 2024, for 420 Medicare patients. Medicare paid $50,690 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 420 Medicare patients who saw Dr. Sing in 2024. The largest group is 65 to 74, with 215 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sing's median patient age at 72, with 58% women.

In 2024, Dr. Sing wrote 443 Medicare Part D claims for 127 patients. 75% of them were for generic drugs. CMS names the drug for 216 of them, across 9 drugs with 11 or more claims each, at $99,302 in total drug cost. In 2023, CMS named 242 claims across 11 drugs.

Dr. Sing accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sing as offering telehealth. CMS counts 185 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Sing, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Sing, published from 2019 to 2023. Dr. Sing's most frequent co-authors are Victoria Jaeger, DO, Richard Arnold Erickson, MD and Christopher Ryan Naumann, MD.

CMS Open Payments shows 10 general payments to Dr. Sing from 6 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 51% of the total. Janssen Pharmaceuticals, Inc paid the most, $210.

Dmand AI lists 2 awards for Dr. Sing, most recently AGA Fellow in 2011.

Dr. Sing graduated from Texas College of Osteopathic Medicine in 1997. Dr. Sing is a member of ACG and AGA.

Dr. Sing is in network with 17 carriers, including United Healthcare, Aetna and Elevance. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.